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Abstract The Sendai virus fuses with host cell membranes in a
pH-independent manner through an unknown mechanism. Here
we report that mild trypsin pre-treatments of Sendai virions, for
example 15 min at 4‡C, give Sendai virions the ability to fuse at a
rate up to 10-fold higher than control. By using human
erythrocytes as host cell membranes, viral fusion was assessed
by hemolysis as well as fluorescence dequenching of octadecyl
rhodamine B chloride. The mild protease treatment strikingly
shortens the lag time taken by the virus to start the fusion
process. Similar data were obtained on reconstituted Sendai virus
envelope. Among proteases, tested as fusion enhancer, trypsin is
more effective than either endoproteinase Lys-C, chymotrypsin,
or endoproteinase Arg-C. After removal of trypsin from treated
virions the fusion rate enhancement remains for hours at room
temperature. The lack of protease specificity, together with the
impossibility to detect any new N-terminal products, suggests
that only a small percentage of viral envelope components are
cleaved, still a large enough number to set the envelope in a
ready-to-fuse state.
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1. Introduction
The early stage of infection of enveloped viruses starts by
binding to cell-surface receptors and terminates by fusion of
the viral envelope with cell membranes [1]. In the in£uenza
virus the fusion is triggered by a well documented pH-induced
conformational change of the HA glycoprotein [2]. The struc-
tural rearrangement occurs at pH 5.5 in the lumen of endo-
somes where after binding the virion is taken up. By lowering
the pH a speci¢c HA hydrophobic peptide passes from a
shielded conformation to an exposed one, then it becomes
inserted into the host-cell membrane [2]. In contrast to the
HA-fusion mechanism, no molecular event triggering fusion
has been described for those enveloped viruses such as Sendai
virus which fuse directly with the host membrane, in a pH-
independent manner [1,3^5].
The viral envelope of Sendai virus (SV), belonging to the
paramyxoviridae family, bears two transmembrane glycopro-
teins, the hemagglutinin-neuraminidase (HN) and the fusion
(F) glycoprotein [3]. The envelope is similar in structure and
lipid composition to the cell membrane which the virion buds
from. The HN glycoprotein binds the virion to the external
cell surface via sialic acid recognition, then the F glycoprotein
induces fusion between the viral envelope and the host-cell
membrane [3^5]. F is produced as a unique inactive peptide
F0 which, once cleaved at Arg-116, becomes the active F1-F2
form [6]. As a consequence of the cleavage, a 26 amino acids
long hydrophobic peptide is located at the F1 N-terminus [3].
Many data indicate that this peptide plays a crucial role in the
viral fusion process [3^5]. A previous study on the F topology
with respect to the viral envelope rules out an insertion of this
hydrophobic peptide in the viral envelope [7]. Therefore the
fusion peptide, in analogy with the in£uenza virus, seems to
be buried in a portion of the F glycoprotein which protrudes
out of the viral envelope. What, if anything, determines the
insertion in the host cell membrane is completely unknown.
The hypothesis that a proteolytic activity may cause fusion
was proposed long ago [8]. Recent data, showing that a pro-
tease of host origin seems associated with F glycoprotein [9],
give new strength to this hypothesis. On the other hand, the
proteases play a crucial role in many steps of SV infection,
since they not only operate post-translational proteolytic ac-
tivation on mature viral particles [3], but also determine SV
organ tropism [10,11].
Here we show that SV, after mild proteolytic treatments,
dramatically enhances the fusion rate with erythrocyte mem-
branes. The lag time occurring after the binding of treated
virus and before its fusion is drastically shortened.
2. Materials and methods
2.1. Virus
Sendai virus, Z strain, was propagated in 10-day-old chicken em-
bryos. After 72 h, the virus was harvested and puri¢ed by di¡erential
centrifugation as in [12].
2.2. Hemolytic assay
SV hemolytic activity was detected by incubating in 20 mM Tris-
HCl, 140 mM NaCl (TBS) pH 7.4, at the temperatures indicated in
the single experiment descriptions, viral particles with 2% (v/v) human
red blood cells (type 0, Rh+), obtained from Centro Trasfusionale,
UniversitaØ La Sapienza, Rome from healthy donors who had given
informed consent. Samples were then diluted 5-fold with cold TBS,
pH 7.4, and intact cells were removed by centrifugation in a bench
centrifuge. The released hemoglobin was evaluated as supernatant
absorbance at 413 nm [12]. 100% hemolysis was determined by addi-
tion of Triton X-100, 1% ¢nal concentration, to an identically treated
sample.
2.3. Ghost preparation
Ghosts were prepared by hypotonic lysis of human erythrocytes in
5 mM sodium phosphate, pH 8.0 at 4‡C, as in [13]. The amount of
ghosts is expressed as mg of protein.
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2.4. Octadecyl rhodamine B chloride (R18) dequenching assay
The assay is based on the properties of R18 £uorescent probe.
Because of the lipid nature of the R18, when incubated with envel-
oped viral particles, it becomes ¢rmly embedded into the viral enve-
lope. If the loading occurs at a high probe concentration, the £uo-
rescence is quenched. Upon fusion, the mixing of the viral envelope
lipids with the lipids of erythrocyte ghosts brings about the dilution of
R18 which goes along with an increase in £uorescence (dequenching).
Therefore, by a continuous monitoring of the £uorescence intensity
increase, we followed the fusion kinetics. Virus labeling with R18 was
performed as in [14]. Fusion between labeled virus and erythrocyte
ghosts was continuously detected as £uorescence increase (excitation
at 560 nm, emission at 590 nm) by a Perkin-Elmer LS-5B spectro-
£uorometer. Fusion was initiated by mixing, directly in the spectro-
£uorometric cuvette, the labeled virus with 1 mg ghost in 3 ml of TBS
at pH 7.4. The £uorescence detected by addition of Triton X-100 (1%
¢nal concentration) represents 100% dequenching.
2.5. Trypsin removal by a⁄nity chromatography
Trypsin removal was achieved by a⁄nity chromatography on a
Sepharose 4B CNBr resin (Pharmacia) conjugated to bovine pancreas
trypsin inhibitor (BPTI). The conjugation procedure was derived from
that described in [15]. Brie£y, 1 ml of drained Sepharose 4B CNBr
was incubated at 4‡C for 14 h with 5 mg of BPTI under gentle stirring
in 5 ml of 0.1 M NaHCO3, 0.5 M NaCl, pH 8.3. At the end of the
incubation period the reaction was blocked by adding 0.2 M glycine
at pH 8.0. 3.2 mg of BPTI resulted, covalently conjugated to 1 ml of
drained gel. Trypsin activity was evaluated with the chromogenic
trypsin substrate NK-benzoyl-DL-arginine-4-nitro-anilide hydrochlo-
ride (BAPNA) [16]. Brie£y, 200 Wl of the sample to be tested was
mixed with 0.2 mg of BAPNA in a ¢nal volume of 1.2 ml of TBS,
pH 7.8. After incubation at 25‡C for 15 min, the reaction was stopped
by adding 0.8 ml of acetic acid 30% (v/v) and the absorbance at 410
nm was measured.
2.6. N-terminal determination
After treatment with trypsin (30 min at 4‡C) viral proteins were
separated by SDS-PAGE under reducing conditions, and blotted
onto Immobilon membrane (Millipore). Protein bands were stained
with Coomassie blue R. HN and F bands were excised and subjected
to amino-terminal sequencing in an Applied Biosystems liquid phase
sequencer 477A.
2.7. Chemicals
Trypsin, TPCK treated, and BPTI were purchased from Merck.
Endoproteinases Arg-C (endo-Arg) and Lys-C (endo-Lys), sequencing
grade, were from Boehringer Mannheim. R18 was from Molecular
Probes Europe BV. Triton X-100 and Surfactant-Amps puri¢ed de-
tergents were obtained from Pierce Chemical Co. All other reagents
were purchased locally from Sigma-Aldrich.
3. Results and discussion
Previous works have shown that trypsin treatments of ma-
ture infective SV at 37‡C for 1 h split the F1 subunit into the
two fragments F32 (32 kDa) and F19 (19 kDa) [7,17], resulting
in F inactivation and loss of the fusogenic property of SV.
The digestion with trypsin is restricted to F as the HN resists
this protease. Surprisingly, during the course of a study using
limited proteolysis of F, we found that brief pre-treatment of
SV with trypsin results in a fusion rate enhancement (FRE).
Fig. 1 shows that trypsin treatment of SV (SVtry), 15 min at
4‡C, dramatically increases the SV hemolytic activity. After 5
min hemolysis is consistently one order of magnitude higher
than in the control. At 37‡C the hemolytic activity of SVtry
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Fig. 1. E¡ect of trypsin pre-treatment on the kinetics of Sendai vi-
rus hemolytic activity. Either 500 Wg of Sendai virus or 50 Wg of re-
constituted Sendai virus envelope (RSVE) was incubated at 4‡C for
15 min with or without 1% trypsin (w/w) in 1 ml TBS pH 7.8; at
the end of the incubation period trypsin was inhibited by 2-fold
weight excess of BPTI. The hemolysis was performed by incubating
1 Wg Sendai virus or 0.1 Wg RSVE with 200 Wl of 2% human eryth-
rocytes suspended in TBS pH 7.4 at (-E-) 25‡C: virus; (- -E- -)
25‡C: RSVE; (-8-) 25‡C: virus preincubated with trypsin; (- -8- -)
25‡C: RSVE preincubated with trypsin; (-a-) 37‡C: virus; (- -a- -
)37‡C: RSVE; (-R-) 37‡C: virus preincubated with trypsin; (- -R- -)
37‡C: RSVE preincubated with trypsin. The hemolysis was stopped
at the indicated time by adding 0.8 ml of chilled TBS pH 7.4 and
determined as described in Section 2. The bars represent the stand-
ard deviations calculated from the data of ¢ve di¡erent experiments
performed with four di¡erent batch preparations.
Table 1
The e¡ect of trypsin removal on the duration of the fusion rate enhancement property acquired by trypsin-pre-treated Sendai virions
Virus Trypsin BPTI-Seph. % Trypsin activitya Recovered hemolytic unitsc þ S.D.d after incubation at 25‡C
10 min 2 h 8 h 18 h
+ 3 3 0.0 1c 0.88 þ 0.1 0.77 þ 0.2 0.57 þ 0.2
+ + 3 100 5.4 þ 0.7 4.9 þ 1.1 2.6 þ 0.7 0.61 þ 0.2
+ + 0.0 nd nd nd nd
3 + 3 65 þ 8.0b nd nd nd nd
3 + + 0.0 nd nd nd nd
+ 3 + 0.0 0.92 þ 0.2 0.90 þ 0.2 0.83 þ 0.2 0.65 þ 0.2
nd, not determined.
a100% of trypsin activity is that resulting after incubation at 4‡C for 10 min of 5 Wg of trypsin with 500 Wg of Sendai virions in 1.0 ml 20 mM Tris-
HCl, 140 mM NaCl, pH 7.8, incubated for 5 min at 4‡C with 50 Wl drained Sepharose 4B gel, then rapidly passed through a Poly-Prep column
(Bio-Rad) in a cold room. Aliquots of 200 Wl were assayed in triplicate for trypsin activity as described in Section 2. 0.0% of trypsin activity results
when the above described trypsin-virus mixture is incubated with 50 Wl of drained Sepharose 4B containing covalently conjugated 160 Wg bpti.
bIncubation of trypsin in the condition described above produces autoproteolysis.
cHemolytic unit is the hemolysis produced upon incubation at 25‡C for 10 min of 1 Wg of Sendai virus with 200 Wl of 2% human erythrocytes, the
hemolysis is stopped by adding 0.8 ml of chilled TBS pH 7.4 and determined as described in Section 2.
dThe standard deviations are calculated from ¢ve di¡erent experiment using four di¡erent batch virus preparations.
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appears not signi¢cantly higher than untreated SV. Further-
more, Fig. 1 shows that similar data are obtained by perform-
ing identical experiments on reconstituted Sendai virus enve-
lope (RSVE), prepared as reported by Moscufo et al. [7]. This
indicates that only the Sendai envelope proteins are involved
in the FRE phenomenon.
To document the FRE in the ¢rst minutes of SV fusion we
used the R18 £uorescence dequenching method (the rationale
of the R18 assay is reported in Section 2). A typical experi-
ment obtained by monitoring fusion of R18-labeled SV with
erythrocytes ghosts is depicted in Fig. 2a,b. The £uorescence
dequenching was recorded both at 25‡C (Fig. 2a) and at 37‡C
(Fig. 2b). SV fusion starts being detectable after a lag time of
2 min at 37‡C (Fig. 2b) and after 5 min at 25‡C (Fig. 2a).
After mild trypsin treatment of SV the lag time appears to be
abolished at 37‡C (Fig. 2b) or reduced to 2 min when the
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Fig. 2. E¡ect of trypsin pre-treatment on the kinetics of £uorescence dequenching of R18-labeled Sendai virions upon fusion with erythrocyte
ghost membranes at (a) 25‡C or (b) 37‡C. Sendai virus particles were ¢rst tagged with R18 as reported in Section 2, then incubated with 1%
trypsin (w/w) at 4‡C for 15 min in TBS pH 7.8; at the end of the incubation period trypsin was inhibited by 2-fold weight excess of BPTI.
The £uorescence dequenching was continuously monitored upon incubation with 1 mg human erythrocyte ghosts of 5 Wg R18-labeled virions ei-
ther pre-treated with trypsin (+Try) or not treated (3Try) as described in Section 2. The ¢gure is representative of one out of three distinct ex-
periments performed with three di¡erent batch preparations.
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assay is performed at 25‡C (Fig. 2a). Remarkably, at 25‡C the
fusion kinetics of SVtry closely resemble that of SV at 37‡C,
the optimal temperature for SV fusion. At 37‡C the maximum
dequenching was reached in approximately 30 min with
SVtry, half the time compared to untreated SV (Fig. 2b).
Previous work has reported that e¡ective SV receptors (100^
200) are about 10% of total SV particles bound to the eryth-
rocyte membrane [13]. Therefore the FRE might be due to an
increase in the number of virions able to fuse per single eryth-
rocyte ghost. Since the £uorescence dequenching reaches the
same maximum value for both SV and SVtry, we infer that
FRE is not correlated with the increase of e¡ective membrane
receptors.
The fact that mild proteolysis reduces the lag time to such
an extent suggests that mild proteolysis induces in SV a ready-
to-fuse state as low pH does in in£uenza virus, where under
low pH the viral fusion takes about 1 s [18].
A possible involvement of trypsin molecules, present during
the fusion assay, could not be ruled out, therefore experimen-
tal procedures were designed to remove trypsin by BTPI af-
¢nity chromatography. Table 1 shows that after complete
trypsin removal SVtry maintains intact its ability to fuse at
a higher rate. Furthermore, Table 1 shows that SVtry loses
the FRE property after incubation at 25‡C for 18 h. These
results indicate that trypsin produces FRE by acting on SV
prior to SV-target membrane interaction and that FRE is a
transient acquired property of SVtry.
Characterization of FRE has been carried out with respect
to the temperature and time parameters. Fig. 3 shows that
maximum FRE is obtained by pre-treatment of SV with 1%
trypsin for 20 and 40 min at 25‡C and 4‡C, respectively, as
determined by R18 dequenching assay. By incubating the SV
with trypsin for a longer period of time, a decrease of FRE,
followed by fusion inactivation, is observed. The latter is the
result of speci¢c cleavage of the F1 subunit into the two frag-
ments F32 (32 kDa) and F19 (19 kDa) [7,17]. However, in the
conditions used for producing FRE, the SDS-PAGE Coomas-
sie pattern is identical to that of the native virus. To further
establish whether new N-termini were produced under condi-
tions that elicit FRE, N-terminus determination was per-
formed on F and HN extracted from SVtry. Also in this
case no di¡erences were detected with respect to the untreated
viral particles. These ¢ndings seem to imply a very low level of
proteolysis of SV envelope proteins, still able to induce the
FRE phenomenon. For example, if the cleaved envelope pro-
teins are less in number than the limit of detectable amount of
the assay (2^4%), the lack of proteolytic evidence is feasible.
How the cleavage of a limited number of proteins might a¡ect
the SV fusion process is completely obscure. In an attempt to
explain it, we note that, if proteolysis of a limited number of
envelope glycoproteins increases their lateral mobility, this
might facilitate the fusion process as suggested by Henis et
al. [19].
To get some insight into the nature of the cleavage site, we
treated SV with either chymotrypsin, endoproteinases Lys-C
or Arg-C and analyzed their ability to induce FRE. As shown
in Table 2, Lys-C is a strong enhancer of SV rate fusion
although weaker than trypsin. Arg-C also shows a slight en-
hancing property. Interestingly, chymotrypsin, which in native
virus speci¢cally directs its action to the HN glycoprotein, is
able to cause a 3-fold increase in SV hemolytic activity. The
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Fig. 3. Initial fusion rate of Sendai virus with erythrocyte ghosts is
a¡ected by the pre-incubation time and temperature conditions of
trypsin. Sendai virions were ¢rst tagged with R18, then incubated
with 1% (w/w) trypsin in TBS pH 7.8 either at 25‡C (R) or at 4‡C
(a), for the time period indicated in the ¢gure. At the end of incu-
bation, trypsin was inhibited by 2-fold weight excess of BPTI. The
initial fusion rate was calculated by the slope of £uorescence de-
quenching continuously monitored upon incubation of 5 Wg R18-la-
beled virus with 1 mg protein of human erythrocyte ghost mem-
branes as described in Section 2. The single data numbers represent
the average of three di¡erent experiments performed using three
batch virus preparations, maximal variations was within 12%.
Table 2
Di¡erent proteases produce an enhancement of Sendai virus rate of hemolysis
Protease Protease/virus ratio (%, w/w) Hemolytic units þ S.D.d
None 3 1
Trypsina 1 5.9 þ 0.6
Chymotrypsina 1.25 2.7 þ 1.1
Lys-Cb 1.25 4.7 þ 0.9
Arg-Cc 3.15 1.8 þ 0.4
Sendai virions were incubated at 25‡C for 20 min at the indicated virus/protease ratio, except for trypsin, which was incubated at 4‡C.
aIncubation was performed in TBS pH 7.8. Trypsin and chymotrypsin were inhibited with BPTI at 2-fold weight excess.
bIncubation was performed in TBS pH 8.4. Endoproteinase Lys-C was inhibited with 2-fold weight excess of leupeptin.
cBefore incubation with Sendai virions endoproteinase Arg-C was ¢rst incubated with 0.5 mM DTT, 1 mM CaCl2 in TBS pH 7.8, then diluted in
TBS pH 7.8 containing Sendai virus to get the protease/virus weight ratio indicated. The Arg-C was inhibited by adding HgCl2 to 10 mM ¢nal
concentration.
dHemolytic units were assayed as described in Table 1 but ¢rst it was assessed that each bu¡er solution used for individual proteases did not a¡ect
the virus-induced hemolysis.
The standard deviation was calculated from the data of ¢ve di¡erent experiments using four batch virus preparations.
M. Tomasi et al./FEBS Letters 423 (1998) 286^290 289
lack of protease speci¢city suggests that an entire polypeptide
rather than a particular site might be involved in FRE induc-
tion.
In conclusion, after mild proteolysis treatments, SV virions
acquire an ability to fuse, as though they had already circum-
vented the rate-limiting step of the entire fusion process.
Therefore this treatment might be helpful to study the inter-
mediates of the SV fusion reaction.
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